Meripilus giganteus ethanolic extract exhibits pro-apoptotic and anti-proliferative effects in leukemic cell lines. by Lenzi M, Cocchi V, Novakovi\u107 A, Karaman M, Saka\u10d M, Mandi\u107 A, Poji\u107 M, Barbalace MC, Angeloni C, Hrelia P, Malaguti M, Hrelia S.
RESEARCH ARTICLE Open Access
Meripilus giganteus ethanolic extract
exhibits pro-apoptotic and anti-proliferative
effects in leukemic cell lines
Monia Lenzi1†, Veronica Cocchi1†, Aleksandra Novaković2, Maja Karaman3, Marijana Sakač2, Anamarija Mandić2,
Milica Pojić2, Maria Cristina Barbalace4, Cristina Angeloni5, Patrizia Hrelia1, Marco Malaguti4*† and Silvana Hrelia4†
Abstract
Background: The interest towards botanicals and plant extracts has strongly risen due to their numerous biological
effects and ability to counteract chronic diseases development. Among these effects, chemoprevention which
represents the possibility to counteract the cancerogenetic process is one of the most studied. The extracts of
mushroom Meripilus giganteus (MG) (Phylum of Basidiomycota) showed to exert antimicrobic, antioxidant and
antiproliferative effects. Therefore, since its effect in leukemic cell lines has not been previously evaluated, we
studied its potential chemopreventive effect in Jurkat and HL-60 cell lines.
Methods: MG ethanolic extract was characterized for its antioxidant activity and scavenging effect against different
radical species. Moreover, its phenolic profile was evaluated by HPLC-MS-MS analyses. Flow cytometry (FCM) analyses
of Jurkat and HL-60 cells treated with MG extract (0–750 μg/mL) for 24–72 h- allowed to evaluate its cytotoxicity, pro-
apoptotic and anti-proliferative effect. To better characterize MG pro-apoptotic mechanism ROS intracellular level and
the gene expression level of FAS, BAX and BCL2 were also evaluated. Moreover, to assess MG extract selectivity
towards cancer cells, its cytotoxicity was also evaluated in human peripheral blood lymphocytes (PBL).
Results: MG extract induced apoptosis in Jurkat and HL-60 cells in a dose- and time- dependent manner by
increasing BAX/BCL2 ratio, reducing ROS intracellular level and inducing FAS gene expression level. In fact,
reduced ROS level is known to be related to the activation of apoptosis in leukemic cells by the involvement of
death receptors. MG extract also induced cell-cycle arrest in HL-60 cells. Moreover, IC50 at 24 h treatment resulted
2 times higher in PBL than in leukemic cell lines.
Conclusions: Our data suggest that MG extract might be considered a promising and partially selective
chemopreventive agent since it is able to modulate different mechanisms in transformed cells at concentrations lower
than in non-transformed ones.
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Background
Mushrooms have been used for centuries as food all
over the world, due to their unique taste and flavour [1].
Archaeological knowledge shows that humans have been
using mushrooms since the Palaeolithic [2] and trad-
itional uses in the treatment of infectious diseases have
been previously described especially in Asian countries
[3]. Over the last few years the interest in therapeutic
potential of different species of lignicolous mushrooms
has increased, justified by the traditional use of these or-
ganisms in the folk medicine of many countries [4, 5].
Meripilus giganteus (MG) is a ligniculous saprobiontic
or parasite mushroom, which fructifies from summer to
autumn at the base of broad-leaved trees, on stumps
and roots, especially on beech wood. It derives its name
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from the remarkable dimensions that it is able to reach:
up to a meter in diameter, protruding from the guest
trunk for more than 30 cm, with a weight up to 10 kg.
The upper portion is zoned, furrowed radially and con-
centrically by streaks of light brown to dark colour, wrin-
kled and covered with numerous scales. The tissue is
initially soft and tenacious, and then becomes fibrous,
leathery and whitish, blackening on contact or rubbing.
Although the young tops are edible after cooking, the
completely grown mushroom is considered not edible
due to its hard and tough consistency. For these reasons
it is considered a species of little value in the culinary
field.
Recently MG has drawn the attention of several scien-
tists on its pharmacological properties such as antioxi-
dant, antimicrobial, and anti-proliferative activities.
Karaman et al. [5, 6] investigated the antioxidant and
antimicrobial activity of numerous lignicolous mush-
room extracts. They demonstrated that MG extract ex-
erts both DPPH radical (DPPH·) and hydroxyl radical
(OH·) scavenging activity. Moreover, they demonstrated
that the antioxidant activity of lignicolous mushroom ex-
tracts directly correlate with their phenolic content, that
in MG are mainly represented by gallic and protocate-
chuic acids.
More recently, Maity et al. [7] isolated from the fruiting
body of MG a polysaccharide (MGPS), which seems to
possess an antioxidant capacity. In detail, it has been
shown that increasing concentrations of MGPS are well
correlated with the ability to scavenge OH· and superoxide
anion radical (O2
·-). In order to have a more complete un-
derstanding of MGPS antioxidant mechanisms, the re-
searchers also investigated its potential as a chelating
agent of ferrous ions (Fe2+). Also in this case the ability of
MGPS to chelate Fe2+ ions was demonstrated [7].
The results obtained from this study seem to con-
firm what was previously demonstrated by Rai et al.
[8], who investigated the antioxidant properties of
different MG extracts, finding a similar antiradical ac-
tion against OH· and O2
·-.
Researchers investigated the antimicrobial potential of
several fungal species, including MG, against five species
of gram-positive bacteria, and four of gram-negative bac-
teria. The methanolic extracts of MG were shown to have
a narrow spectrum of action against gram-negative bac-
teria, while strongly inhibit the growth of gram-positive
species [6]. These data implement results previously ob-
tained by Rai and co-workers [9], who described a moder-
ate antibacterial action of MG against E. coli and P.
aeruginosa.
Many substances with anti-proliferative effect have
been isolated from fungi. Tomasi. et al. [10] analysed the
effects of numerous methanolic mushroom extracts and
demonstrated that MG exerts antiproliferative activity
on 3LL murine lung cancer cell line. Previously Narbe et
al. [11] isolated ergosterol peroxide from MG extract,
which is known for its antiproliferative properties on
both solid and liquid cancer models [12, 13].
Aim of the study
Considering the numerous biological and pharmaco-
logical properties of MG extracts, it is possible to
hypothesize its application as a chemopreventive agent
in leukaemia. Therefore, the aim of this study was to
evaluate the antitumor potential of MG ethanolic ex-
tract, fully characterized in its phenolic profile and anti-
oxidant properties, in two different leukaemic cell lines.
More specifically, its pro-apoptotic and anti-proliferative
effects were analysed in human lymphoblastic leukaemia
cells (Jurkat cells) and in human promyelocytic leukae-
mia cells (HL-60 cells). Moreover, expression level of
genes involved in apoptotic pathways was evaluated. In
addition to evaluating its selectivity towards cancer cells,
its cytotoxic effect on non-transformed human periph-
eral blood lymphocytes (PBL) was also tested.
Methods
Materials
Sodium carbonate, Aluminium trichloride, Sodium acet-
ate, Quercetin, Formic acid, FRAP reagent, Sodium nitro-
prusside (SNP), Griess reagent, TBA-reagent, Nitro Blue
Tetrazolium (NBT), Ethylenediaminetetraacetic acid
(EDTA), Ascorbic acid (AA), Gallic acid (GA), DPPH so-
lution, Thiobarbituric acid (TBA), Trichloroacetic acid
(TCA), Dimethyl sulfoxide (DMSO), Fetal Bovine Serum
(FBS), Formaldehyde, Hanks’ balanced salt solution
(HBSS), Histopaque-1077, Hoechst 33342, L-Glutamine
(L-GLU), Penicillin-Streptomicin (PS), Phitohemagglutinin
(PHA), Phosphate buffered saline (PBS), Primers (BAX,
BCL2, FAS, GADPH, 18S rRNA), Roswell Park Memorial
Institute (RPMI)1640 medium, Triton X-100,
2′-7′-dichlorodihydrofluorescin diacetate (DCFH-DA)
were obtained from Sigma Co. (St. Louis, MO).
Folin-Ciocalteu reagent (FC) was obtained from Merck
(Darmstadt, Germany). Methanol (MeOH), Ethanol
(EtOH) were purchased from Zorka (Šabac, Serbia).
Guava Cell Cycle Reagent, Guava Nexin Reagent, Guava
ViaCount Reagent (all from Merck, Darmstadt, Germany).
RNeasy Mini Kit (from QIAGEN GmbH, Hilden,
Germany), SsoAdvanced Universal SYBR Green Super-
mix, iScript cDNA Synthesis Kit (both from BIO-RAD,
Hercules, CA, USA).
Meripilus giganteus extract preparation
The extract was provided by the Institute of Food Tech-
nology (FINS) (Novi Sad, Republic of Serbia) as a part of
the collaborative activities included in the Horizon 2020
project, FOODSTARS.
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Mushrooms were collected in 2012 in the Sikole area
(Serbia), fungal material was identified by Professor Maja
Karaman (University of Novi Sad), expert in mycology.
A voucher specimen of the fungal material has been de-
posited at “Buns herbarium” (Department of Biology and
Ecology, University of Novi Sad, Serbia) with voucher
number: 12–00697. After the exact determination of
specie, mushrooms were stored at − 20 °C, freeze dried
(Martin Christ GmbH, Germany) and ground to a fine
powder. The extraction was obtained by macerating the
powder (1 g) with 10 mL of 80% ethanol (EtOH) for
24 h in a shaker at room temperature (25 °C). The ex-
tract was filtered through Whatman No. 4 filter paper
and, subsequently, the solvent was evaporated to dryness
in a Rotavapor at 40 °C (Büchi, Switzerland) and stored.
For further analysis the dried extract was dissolved in
ethanol to obtain 5% (w/w) solution.
Total phenolic content
Total phenolic content (TP) was determined in the etha-
nolic extract according to the method by Singleton et al.
[14] and modified by Novaković et al. [15]. Briefly,
125 μL of Folin–Ciocalteu (0.1 M) reagent were added
to 25 μL of the extract. After 10 min incubation, 100 μL
of 7.5% sodium carbonate was added and the reaction
mixture was incubated for 2 h. Absorbance was read at
690 nm in a plate reader (Multiskan Ascent, Thermo
Electron Corporation). A standard curve was con-
structed using gallic acid in the range of 0 to
1000 μmol/L. Total phenolic content was expressed as
mg gallic acid equivalents (GAE)/g of extract on dry
weight basis.
Total flavonoid content
The total flavonoid (TF) content of the ethanolic extract
was determined by Chang et al. [16] modified for the
measurements in a 96-well plate reader [15]. Briefly,
90 μL of methanol, 6 μL of aluminium trichloride
(0.75 M), 6 μL of sodium acetate (1 M) and 170 μL of
distilled water were added to 30 μL of the extract. After
30 min incubation absorbance was measured at 414 nm.
A standard curve was constructed using quercetin in the
range of 1.25–100 μg/mL. Results were expressed as mg
quercetin equivalents (QE)/g of extract dry weight.
HPLC–MS/MS determination of the phenolic compounds
Phenolic compounds were determined in the ethanolic
extract according to the method of Orčić et al. [17],
using an Agilent 1200 series liquid chromatograph
equipped with a Zorbax Eclipse XDB-C18 RR 4.6 mm ×
50 mm × 1.8 mm column (Agilent Technologies) at 40 °
C. The separated compounds were detected by an Agi-
lent series 6410A triple-quadrupole mass spectrometer
with electrospray ionization (ESI). MassHunter ver.
B.03.01. Software (Agilent Technologies) was used for
instrument control and data analysis. The mobile phase
consisted of 0.05% formic acid (A) and methanol (B)
with a flow rate of 1 mL/min. The following gradient
elution was used: at 0 min, 30% B, at 6.00 min reaching
70% B, then at 9.00 min 100% B, holding until
12.00 min, followed by equilibration time of 3 min to
the starting mixture of 30% B. Samples were injected
automatically, the injection volume for all samples was
5 μL. ESI parameters were: drying gas (N2) at 350 °C,
flow of 9 L/min, nebulizer gas pressure of 40 psi, capil-
lary voltage of 4 kV with negative polarity. All com-
pounds were quantified in dynamic MRM mode
(multiple reaction monitoring mode). The stock solution
was prepared by mixing the solutions of 44 individual
phenolic acids and flavonoids at concentration of
100 μg/mL each. Working standard solutions were pre-
pared by dilution of stock solution in methanol–water
(1:1, v/v) to obtain final concentrations in the range of
0.0015 to 25.0 μg/mL. Concentrations of compounds in
the extract were determined from the peak areas using
the equation for linear regression obtained from the cali-
bration curves (r2 > 0.995) and expressed as μg/g dry
weight.
DPPH radical (DPPH·) scavenging activity
Free radical scavenging activity based on the monitoring
of DPPH· radical transformation in the presence of the
ethanolic extract was determined as previously described
by Espin et al. [18]. Briefly, the reaction mixture in the
wells consisted of the extract (10 μL), DPPH solution
(60 μL) and methanol (180 μL). The reaction mixture
was incubated in the dark for 60 min at 25 °C. The ab-
sorbance was measured at 540 nm using a plate reader
(Multiskan Ascent, Thermo Electron Corporation). Each
sample was tested at five different concentrations in the
range of 7.5–200 μg/mL to obtain IC50. The IC50 value
(μg/mL) was defined as the concentration of an antioxi-
dant extract which was required to quench 50% of the
initial amount of DPPH· under the experimental condi-
tions given.
Ferric reducing antioxidant power (FRAP)
FRAP assay was performed on the ethanolic extract ac-
cording to modified procedure of Benzie et al. [19]. The
FRAP reagent is a mixture of 300 mM acetate buffer
(pH 3.6): 10 mM 2,4,6-tris(2-pyridyl)-s-triazine (TPTZ)
in 40 mM HCl: 20 mM FeCl3 (10:1:1, v/v/v). The reac-
tion mixture in the wells consisted of the extract
(10 μL), FRAP reagent (225 μL) and distilled water
(22.5 μL). Absorbance was measured at 620 nm, after
6 min of incubation. Ascorbic acid was used to construct
the standard curve and results were expressed as mg
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ascorbic acid equivalents (AAE)/g of extract on dry
weight basis.
Nitric oxide radical (NO·) scavenging capacity
NO scavenging capacity was determined according to
the procedure of Green et al. [20]. Briefly, the reaction
mixture in the test tubes consisted of the extract
(30 μL), sodium nitroprusside (SNP) (500 μL) and
0.067 mol/L phosphate buffer at pH 7.4 (500 μL). Test
tubes were incubated under light exposure at 25 °C for
90 min. After incubation, Griess reagent consisting of
0.2% solution of N-(1-naphthyl) ethylenediamine dihy-
drochloride (NEDA): 2% solution of sulphanilamide in
4% of phosphoric acid (1:1, v/v) was added (1 mL). Ali-
quots of the reaction mixture (250 μL) were transferred
to the plate, and their absorbances were measured using
a plate reader at 540 nm (Multiskan Ascent, Thermo
Electron Corporation). Samples were tested at five differ-
ent concentrations in the range of 74–591 μg/mL to ob-
tain IC25, defined as the concentration of the extract
which scavenges 25% of the initial amounts of NO..
Hydroxyl radical (OH·) scavenging capacity
Determination of scavenging activity on OH·, gener-
ated in Fenton reaction, was performed from the re-
action of 2-deoxyribose degradation [21]. The reaction
mixture contained 100 μL of 2-deoxyribose, 100 μL of
FeSO4 (127 mg FeSO4·7 H2O in 50 mL of phosphate
buffer, pH 7.4) and 10 μL of the tested extract. Phos-
phate buffer was added to the mixture to the final
volume of 3 mL and incubated at 37 °C for 1 h. Two
millilitres of TBA-reagent (10.4 mL of 10% HClO4,
3 g of thiobarbituric acid (TBA) and 120 g of 20%
trichloroacetic acid (TCA) dissolved in 800 mL of dis-
tilled H2O) and 0.2 mL of 0.1 M EDTA were added
to terminate the reaction. The absorbance was mea-
sured at 532 nm using a UV-Vis spectrophotometer
(Agilent Technologies, Santa Clara, CA). To obtain
IC50 value, the range of concentrations of 0.7–4.7 μg/
mL MG extract was tested.
Superoxide anion radical (O2
-.) scavenging activity
Superoxide anion radical scavenging activity of the etha-
nolic extract was determined by measuring its ability to
neutralize superoxide anion radicals generated during
aerobic reduction of nitro blue tetrazolium (NBT) by
NADH, mediated by 5-methylphenazin-5-ium methyl
sulphate (PMS) [22]. The reaction mixture in a test tube
was composed by 677 μM NADH (100 μL), 60 μM PMS
(100 μL), 144 μM NBT (200 μL), 0.017 mol/L phosphate
buffer at pH 8.3 (1,1 mL) and the extract (10 μL). After
5 min of incubation, aliquots (250 μL) were transferred
to the plate wells (Multiskan Ascent, Thermo Electron
Corporation), and their absorbances were measured at
540 nm. Five different concentrations of each sample in
the range of 2.4–33.1 μg/mL were tested to obtain IC50,
defined as the concentration of the extract able to scav-
enge 50% of O2
·-.
Jurkat and HL-60 cell culture and treatments
Jurkat cells (acute T-cell lymphoblastic leukaemia) and
HL-60 cells (acute promyelocytic leukaemia) were pur-
chased at the “Istituto Zooprofilattico” of Lombardia and
Emilia-Romagna (Brescia, Italy). Both cell lines were cul-
tured at 37 °C and 5% CO2 in Roswell Park Memorial
Institute (RPMI)1640 medium supplemented with 1%
Penicillin-Streptomicin (PS), 1% L-Glutamine (L-GLU)
and 10% of Fetal Bovine Serum (FBS) for Jurkat cells
and 20% of FBS for HL-60 cells (all from Sigma Aldrich,
Saint Luis, MO, USA).
The MG extract was dissolved in RPMI at 20% of
DMSO (v/v), in order to obtain a Working Solution
50 mg/mL. The solution thus prepared has been stored
for a maximum of 72 h at − 20 °C and protected from
light. The concentrations of the different extracts tested
ranged from 0 to 750 μg/mL and the concentration of
DMSO was always within the 0.05–1% range in all ex-
perimental conditions.
In particular, 3.75 × 105 of Jurkat cells were treated
with increasing concentrations of extract from 0 to
500 μg/mL and incubated for 24, 48 and 72 h. The cell
density never exceeded the critical value of 3.00 × 106
cells/mL of medium. One hundred twenty-five thousand
of HL-60 cells were treated with increasing concentra-
tions of extracts from 0 to 750 μg/mL and incubated for
24, 48 and 72 h. The cell density never exceeded the
critical value of 1.00 × 106 cells/mL of medium.
PBL culture and treatments
Authorization to the use of human blood samples (Buffy
coat), for research purposes, was obtained from AUSL of
Bologna, Italy, S. Orsola-Malpighi Hospital -PROT GEN
No. 0051937, and written informed consent was ob-
tained by AUSL of Bologna, Italy, S. Orsola-Malpighi
Hospital from donors for the use of their blood for sci-
entific research purposes. PBL were isolated from the
whole peripheral blood of 5 AVIS healthy donors (Asso-
ciation of Italian Blood Volunteers), by density gradient
centrifugation with Histopaque-1077 (Sigma Aldrich,
Saint Luis, MO, USA) [23].
PBL were cultured at 37 °C and 5% CO2 in RPMI-
1640 supplemented with 1% PS, 1% L-GLU, 15% FBS
and in the presence of 0.5% Phitohemagglutinin (PHA)
(Sigma Aldrich, Saint Louis, MO, USA) for 48 h to
stimulate cell proliferation. Two hundred thousand PBL
were than treated with increasing concentrations of ex-
tract from 0 to 1000 μg/mL and incubated for 24 h.
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Flow cytometry (FCM)
All FCM analyzes reported below were performed using
a Guava easyCyte 5HT flow cytometer equipped with a
class IIIb laser operating at 488 nm (Merck, Darmstadt,
Germany).
Cytotoxicity analysis by FCM
The cytotoxicity induced by MG was evaluated by the
Guava ViaCount Assay protocol. In particular, the per-
centage of viable cells was assessed by FMC using the
Guava ViaCount Reagent (Merck, Darmstadt, Germany)
that contains the dye Propidium Iodide (PI) and ana-
lyzed by Guava ViaCount software [24].
The results obtained in the samples treated with differ-
ent concentrations of extracts were normalized on those
obtained in control cultures and used to calculate the
IC50 by interpolation from the dose-response curve. In
the subsequent experiments concentrations ≤ IC50 were
used.
Analysis of apoptosis by FCM and optical microscopy
The discrimination of the death mechanism was
assessed by the Guava Nexin Assay Protocol. In par-
ticular, the percentage of live, apoptotic and necrotic
cells was assessed by FCM using the Guava Nexin
Reagent (Merck, Darmstadt, Germany) that containing
7-aminoactinomycin D (7-AAD) and Annexin-V-PE
and analyzed by Guava Nexin software as previously
reported [24, 25].
Moreover, the nuclear condensation and fragmenta-
tion associated with the apoptotic process was evalu-
ated by fluorescence microscopy with 100X
magnification. After treatment, 1.00 × 106 cells were
loaded into cytospin chamber and centrifuged ad
450 rpm for 10 min. Cells were than fixed in formal-
dehyde 3.7%, washed in PBS pH 7.2, permeabilized in
0.15% triton X-100 (all Sigma-Aldrich, Saint Louis,
MO, USA) and nuclei were stained using Hoechst
33342 500 nM as previously reported [26].
Cell-cycle analysis by FCM
The effect of MG on the cancer cells replication was
evaluated by GUAVA Cell-Cycle Assay protocol. In par-
ticular, the percentage of cells in the different phases of
the cell-cycle (G0/G1, S, G2/M) was assessed by FCM
using the Cell-Cycle Reagent (Merck, Darmstadt,
Germany) that containing PI and analysed by Guava
Cell-Cycle software [24].
RNA extraction
After 16 h treatments, total RNA was extracted from
Jurkat and HL-60 cells by using RNeasy Mini Kit (QIA-
GEN GmbH, Hilden, Germany), following the manufac-
turer’s protocol. The yield and purity of the RNA were
measured using NanoVue Spectrophotometer (GE
Healthcare, Milan, Italy).
Analysis of FAS, BAX and BCL2 mRNA expression levels
by reverse transcriptase polymerase chain reaction
cDNA was obtained by reverse transcribing mRNA
starting from 1 μg of total RNA using iScript cDNA
Synthesis Kit (BIO-RAD, Hercules, CA, USA), following
the manufacturer’s protocol. The subsequent polymerase
chain reaction (PCR) was performed in a total volume of
10 μl containing 2.5 μl (12.5 ng) of cDNA, 5 μl SsoAd-
vanced Universal SYBR Green Supermix (BIO-RAD,
Hercules, CA, USA) and 0.5 μl (500 nM) of each primer.
The primers used are reported in Table 1 18S rRNA and
GAPDH were used as reference genes.
Intracellular ROS level
After 24 h treatment Jurkat and HL-60 cells (1.00 × 106
cells/mL), were washed twice in HBSS, and incubated
with 5 μM 2′-7′-dichlorodihydrofluorescin diacetate
(DCFH-DA) (Sigma-Aldrich, Saint Louis, MO, USA), for
20 min at 37 °C. When inside the cell, DCFH-DA is dea-
cetylated and can be oxidized by ROS to the highly
fluorescent 2′,7′-dichlorofluorescein (DCF). DCF fluor-
escence was measured using a multi-well plate reader
(Wallac Victor2, PerkinElmer) at excitation and emission
wavelengths of 485 and 535 nm, respectively [27]. Fluor-
escence values were reported as percentage of intracellu-
lar ROS with respect to control.
Statistical analysis
Results on TP and TF content, on DPPH·, OH·, O2
·-,
NO· scavenging activity and FRAP are expressed as
mean ± standard deviation (SD). All results on cell
viability, analysis of apoptosis, cell-cycle, gene expres-
sion and intracellular ROS are expressed as mean ±
standard error mean (SEM) of at least five independ-
ent experiments. For the statistical analysis of apop-
tosis, cell-cycle and gene expression level we used the
Analysis of Variance for paired data (repeated
ANOVA), followed by Bonferroni as the post-test. For
statistical analyses of ROS intracellular level we used
the t-test for paired data. All the statistical analyses
Table 1 Both forward and reverse primer sequences for BAX,






18S rRNA CAGAAGGATGTAAAGGATGG TATTTCTTCTTGGACACACC
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were performed using GraphPad Software Prism 6
(GraphPad Software LLC, La Jolla, CA, USA).
Results
MG phenolic composition
TP content of MG ethanolic extract resulted in 106.33 ±
11.27 mg GAE/g extract, while TF content resulted in
13.84 ± 1.11 mg QE/g extract. HPLC-MS/MS analyses
revealed the presence of p-OH-benzoic acid, protocate-
chuic acid, p-coumaric acid and caffeic acid. Quantita-
tive determination is reported in Table 2.
Antioxidant activity of MG extract
Since different mechanisms are involved in the
neutralization of different radical species Table 3 reports
the antioxidant activity of MG extract measured accord-
ing to five methods, DPPH., NO., OH· and O2
·- scaven-
ging capacity and FRAP.
Cytotoxicity analysis on Jurkat and HL-60 cells
After 24 h treatment the IC50 for MG was found to be
385 μg/mL in Jurkat cells and equal to 461 μg/mL in
HL-60 (Fig. 1).
Apoptosis analysis on Jurkat and HL-60 cells
In order to evaluate the involvement of a specific cell
death mechanism in the demonstrated cytotoxic action,
the analysis of apoptosis possibly induced at different
concentrations on Jurkat and HL-60 cells was per-
formed, after 24, 48 and 72 h, in order to determine if
the event was dose and/or time-dependent.
Specifically, the cells were treated with concentrations
≤ IC50 and the double staining Annexin V-PE / 7-AAD
allowed to measure the percentage of live, apoptotic and
necrotic cells.
In Jurkat cells, MG showed a dose- and time-dependent
induction of apoptosis. In fact after 24 h there was a sta-
tistically significant increase of apoptotic cells per-
centage at the concentration 125 μg/mL equal to 2
times compared to the control (7.3% vs 3.1%) and an
increase equal to 3 times at 250 μg/mL (8.4% vs
3.1%). After 48 h, on the other hand, a doubling of
the fraction of apoptotic cells compared to 24 h was
observed at both concentrations tested. Specifically
there was a 4 times increase at 125 μg/mL (13.3% vs
3.5%) and a 6 times increase at 250 μg/mL (21.2% vs
3.5%). At 72 h the trend is comparable (Fig. 2a, b, c).
In HL-60 (Fig. 3) after 24 h there was evidence at the
concentration of 125 μg/mL, a statistically significant in-
crease in the fraction of apoptotic cells, equal to 3 times
compared to control (11.3% vs. 3.8%), parallel to an
Table 2 Content of phenolic compounds in MG extract
Phenolic compounds μg/g dry weight
p-OH-benzoic acid 23.9 ± 3.66
Protocatechuic acid 1.26 ± 0.13
p-coumaric acid 0.2 ± 0.05
Caffeic acid 1.3 ± 0.11
Values are expressed as means ± SD of triplicate measurements. Phenolic acid
contents were determined by HPLC-MS/MS as described in the
Methods section
Table 3 Antioxidant activity of MG extract
DPPH. (IC50)
a μg/mL 57.77 ± 2.48
NO. (IC25)
b μg/mL 148.04 ± 4.98
OH· (IC50)
a μg/mL 1.74 ± 0.2
O2
− (IC50)
a μg/mL 24.28 ± 2.06
FRAPc mg (AAE)/g 22.54 ± 3.51
Values are expressed as means ± SD of triplicate measurements. Antioxidant
activity was determined as described in the Methods section
aIC50 (μg/mL), concentration of extract that neutralized 50% of DPPH·, OH·
and O2
.-
bIC25 (μg/mL), concentration of extracts that neutralized 25% of NO
cFerric reducing antioxidant power (FRAP) is expressed as mg ascorbic acid
equivalents/g extract dry weight (mg AAE/g d.w)
Fig. 1 Effect of MG on viability of Jurkat and HL-60 cells. Cell viability
was determined as described in Methods section. IC50 obtained by
curve fitting of viable cells after 24 h treatment with MG for Jurkat cells
(a) and HL-60 cells (b). Data are presented as means ± SEM of five
independent experiments
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increase of 3 and 4 times, for 250 μg/mL and 375 μg/
mL, respectively (11.1% vs. 3.8, 16.2% vs 3.8%). After
48 h, the trend remained comparable to 24 h for the
125 μg/mL concentration (11.6% vs 3.7%), while for
250 μg/mL a further increase in the number of apoptotic
cells was observed, equal to at 4 times the control
(15.2% vs. 3.7%); the same concentration, at the longest
treatment time (72 h), was instead associated with an in-
crease equal to 6 times (8.6% vs 1.4%). Therefore, these
data demonstrate a dose- and time-correlated trend at
all times analysed, particularly evident for the concentra-
tion of 250 μg/mL.
Considering the demonstrated pro-apoptotic effect, we
wanted to confirm the results obtained by FCM, also by
fluorescence microscopy analysis, visualizing the mor-
phological changes characteristic of apoptosis, such as
nuclear condensation and fragmentation (Fig. 4).
Cell-cycle analysis on Jurkat and HL-60 cells
In order to evaluate whether the induction of apop-
tosis caused by MG was an independent event or
subsequent a slowing/blocking of the cell-cycle, the
Jurkat and HL-60 cells were treated with the concen-
tration selected on the basis of the results obtained
from the apoptosis analysis and incubated at the same
treatment times. The PI staining allowed to highlight
that MG does not show any activity on the cell-cycle
of Jurkat cells, at the tested concentration (250 μg/
mL), at any treatment time (Fig. 5a, b, c).
Conversely, on HL-60 cells, after 24 h a slowing of the
cell-cycle is observed in the G2/M phase, underlined by
an increase in the cell fraction equal to a 33.1% vs 25.2%
in the control cultures. At 48 h instead, there was an in-
crease in the number of cells in the G0/G1 phase (47.7%
vs 35.1%), with a consequent reduction in S phases
(30.0% vs 40.4%) and G2/M (21.8% vs 24.5%); the same
behaviour is observed at 72 h (Fig. 6a, b, c).
FAS, BAX and BCL2 expression analysis on Jurkat and HL-
60 cells
mRNA expression analysis of three genes involved in
apoptotic pathways regulation such as FAS, BAX, BCL2
were performed.
Figure 7 shows that MG extract after 16 h treat-
ment significantly induced, in both Jurkat and HL-60,
FAS mRNA expression level (Fig. 7a, c) and increases
the ratio between BAX and BCL2 mRNA expression
(Fig. 7b, d).
Intracellular ROS level
To characterize the mechanism behind MG capability to
induce apoptosis in leukaemia cells its potential modula-
tory effect on intracellular ROS level was investigated in
both Jurkat and HL-60 cells by the DCFH-DA assay. As
Fig. 2 Increase in apoptotic Jurkat cell fraction after MG treatment.
Apoptosis was evaluated at 24 h (a), 48 h (b) and 72 h (c), as
reported in Methods section. Each bar represents means ± SEM of
five independent experiments. Data were analysed using repeated
ANOVA followed by Bonferroni post-test.**p < 0.01 vs control; ***p <
0.001 vs control
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shown in Fig. 8, ROS intracellular level was significantly
decreased respect to control by MG 250 μg/mL after
24 h treatment in both cell-lines.
Cytotoxicity analysis on PBL
The analysis of the viability of PBL following MG treat-
ment for 24 h allowed to obtain an IC50 value of 761 μg/
mL, which demonstrated a cytotoxicity lower than that
manifested on the two leukaemia cell lines (Fig. 9).
Discussion
Great attention has been dedicated to the potential of
many extracts and naturally occurring compounds in the
prevention/counteraction of chronic diseases [28–30].
Numerous studies have demonstrated that molecules
that exhibit antioxidant properties such as polyphenols,
isothiocyanates and other compounds counteract cardio-
vascular, neurodegenerative diseases and the carcino-
genic process at various levels by acting through
multiple mechanisms [31–34]. Extracts from plant
origin may contain various compounds with useful
biological properties, thus configuring themselves as
complex mixtures with multi-target activities, capable
of inhibiting or modulating simultaneously numerous
critical targets [25, 35, 36].
Edible mushrooms, including MG, possess antioxidant,
antimicrobial and anti-inflammatory properties [7, 37–
39], suggesting their potential application as chemopre-
ventive agents. The purpose of this work was, therefore,
Fig. 3 Increase in apoptotic Jurkat cell fraction after MG treatment.
Apoptosis was evaluated at 24 h (a), 48 h (b) and 72 h (c), as
reported in Methods section. Each bar represents the mean ± SEM of
five independent experiments. Data were analysed using repeated
ANOVA followed by Bonferroni post-test. **p < 0.01 vs control; ***p
< 0.001 vs control
Fig. 4 Fluorescence microscopy analysis of Jurkat and HL-60 after
MG treatment. Nuclear condensation and fragmentation associated
to apoptotic process on Jurkat and HL-60 cells was evaluated by
fluorescence microscopy at 100x magnification after 24 h of 250 μg/
mL MG treatment (b, d) respect to control culture (a, c). White
arrows indicate condensed and/or fragmented nuclei as marker
of apoptosis
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to evaluate whether MG extract is able, thanks to its anti-
oxidant activity to exhibit chemopreventive activities. The
research focused on the evaluation of numerous in vitro
end-points in two leukemic cell lines (Jurkat and HL-60
cells) and subsequently in healthy lymphocytes (PBL).
Among scientific literature, strong discrepancies can
be observed when comparing TP and TF content of
MG extracts., These differences are probably due to
extraction methods, mushroom provenance and the
fact that TP and TF might be expressed in different
ways. Papers reporting the TP of wild edible mush-
rooms other than MG differ in a very wide range in
the order of mg/mL [6, 40–42].
HPLC-MS/MS analysis of MG ethanolic extract re-
sulted in quantification of four phenolic acids, giving the
total sum of 26.66 μg/g. Dominant phenolic acid was
p-hydroxybenzoic acid, in accordance with previously
published data on MG [6]. All the differences that can
be observed when comparing the previously published
data for MG and other wild mushrooms should be at-
tributed to the changes that occur during the mush-
rooms harvest and postharvest period of time, due to
the enzymatic and oxidative processes [43, 44].
It has been shown that the strong antiradical activity
of mushroom extracts on different radical species is due
to the presence of different phenolic compounds and
flavonoids [45, 46].
Fig. 5 Cell-cycle analysis of Jurkat cells treated with MG extract.
Fraction of Jurkat cells in the different phases of the cell cycle after
MG treatment for 24 h (a) 48 h (b) and 72 h (c) was evaluated as
reported in Methods section. Each bar represents the mean ± SEM of
five independent experiments. Data were analysed using repeated
ANOVA followed by Bonferroni post-test and revealed no statistically
significant differences
Fig. 6 Cell-cycle analysis of HL-60 cells treated with MG extract.
Fraction of HL-60 cells in the different phases of the cell-cycle after
MG treatment for 24 h (a) 48 h (b) and 72 h (c) was evaluated as
reported in Materials and Methods section. Each bar represents the
mean ± SEM of five independent experiments. Data were analysed
using repeated ANOVA followed by Bonferroni post-test. *p < 0.05 vs
control; **p < 0.01 vs control; ***p < 0.001 vs control
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Determination of DPPH· scavenging capacity is a com-
monly employed assay in antioxidant studies, Ferreira et
al. [47] analysed DPPH· scavenging capacity of different
mushroom methanolic extracts finding that DPPH EC50
was in the range of 8–50 mg/mL. Similarly, Puttaraju et
al. [48] analysed methanolic and water extracts of 23 dif-
ferent edible mushrooms and found that DPPH EC50
values were in the same order of magnitude.
Only few studies have previously evaluated MG ex-
tracts antioxidant activity. Our data show MG ethanolic
extract ability to scavenge different radicals such as
DPPH·, O2
·-, OH·, NO and to exert antioxidant activity
by reducing Fe3+ ions (FRAP). These data are in agree-
ment with those previously published [5, 6, 8] which
found that MG water, ethanolic, methanolic and chloro-
formic extracts exert DPPH· and OH· radical scavenging
activity with EC50 values in the order of μg/mL. Simi-
larly, FRAP result is in agreement with previous report
[6]. All together, these data suggest that MG extract is
characterized by a strong radical scavenging activity
Fig. 7 Effect of MG extract treatment on FAS, BAX and BCL2 expression level in Jurkat (a, b) and HL-60 (c, d) cells. Total RNA was isolated, and
the mRNA level of target genes was quantified using RT-PCR normalized to 18S rRNA and GAPDH as reference genes. Triplicate reactions were
performed for each experiment. Each bar represents the mean ± SEM of three independent experiments. Data were analysed by one-way ANOVA
followed by Bonferroni’s test. *p < 0.05 vs control; **p < 0.01 vs control;***p < 0.001 vs control
Fig. 8 Intracellular ROS level in Jurkat and HL-60 cells treated with
MG at 250 μg/mL for 24 h. Each bar represents the mean ± SEM of
three independent experiments. Data were analysed by t-test,
**p < 0.01 vs control
Fig. 9 Effect of MG on viability of PBL. IC50 was obtained by curve
fitting of viable cells after 24 h treatment. Data are presented as
mean ± SEM of five independent experiments
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mainly related to its phenols content as previously re-
ported by Karaman et al. [6].
Due to the strong antioxidant activity, it was pos-
sible to hypothesize a chemopreventive role for MG
ethanolic extract.
A chemopreventive agent can act in different ways:
by modulating the biotransformation enzymes in-
volved in the activation/detoxification processes of
carcinogens or by stimulating apoptosis and inhibiting
the proliferation of transformed cells [49].
Even though some studies reporting pro-apoptotic
and anti-proliferative effects of mushroom extract
have already been published [50, 51], to our know-
ledge no data on MG effects in leukemic cell lines
are available. Therefore, specific mechanisms of cell
death, apoptosis and/or necrosis and MG ability to
modulate cell-cycle were investigated.
Results show that MG is able to significantly induce
apoptosis in a dose- and time- related manner in both
leukemic cell lines. Moreover, it does not modulate, in
any way, Jurkat cell-cycle while it inhibits HL-60 prolif-
eration by causing a slowdown in G2 /M phase after
24 h treatment, which results in a real block after 48 h
in G0/G1 phase with a corresponding decrease in the
percentage of cells in phase S and G2/M. This effect is
confirmed after 72 h of treatment. These data are in
agreement with previous reports showing that different
flavonoids and polyphenols exert cell-cycle arrest in
HL-60 [52]. A possible hypothesis to explain the differ-
ences between MG treatment effect on Jurkat and
HL-60 cell cycle resides in the substantial differences
that exist between these two cell lines. Jurkat cells are
a lymphocyte cell line in an advanced state of matur-
ation and differentiation, while HL-60 are a highly
undifferentiated immature promyelocytic cell line. Fu-
ture studies are needed to clarify whether these differ-
ences are responsible for the different effect of MG
on the cell cycle [53].
In order to elucidate which mechanism is responsible
for the pro-apoptotic effect we evaluated the expression
level of genes such as FAS, BAX and BCL2.
FAS receptor belongs the family of death receptors, it is
located on the cell membrane and the binding to its ligand
leads to apoptosis through caspase-8 activation which dir-
ectly activates caspase 3 and simultaneously promote Bid
cleavage leading to mitochondrial membrane potential
loss [54]. Moreover, it has been demonstrated that FAS
over-expression induces apoptosis in Jurkat cell and other
malignant T-cell lines [55]. In our study, 16 h treatment
with MG induced FAS mRNA expression in both Jurkat
and HL-60 cells. Bax and Bcl-2 are mitochondrial pro-
teins, while Bax exhibits pro-apoptotic activity, Bcl-2 is
considered an anti-apoptotic and is often overexpressed in
different cancers [56, 57]. In order to induce apoptosis in
cancer cells, most therapies are based on stimulating the
expression of Bax and/or suppressing Bcl-2 protein. In
this study we contemporaneously observed, in Jurkat cells,
an increase of BAX and a decrease of BCL2 gene expres-
sion level after 250 μg/mL MG treatment. Otherwise, in
HL-60 cells a reduction of BCL2 level was found, while
BAX was not affected. Our data demonstrate that BAX/
BCL2 mRNA expression ratio significantly increased in
both cell lines suggesting the involvement of these two
proteins in the progression of the apoptotic cascade in-
duced by MG.
It is known, that high ROS intracellular level is a com-
mon characteristic of leukaemic and other cancer cells
[58]. This feature has been observed in numerous
Fig. 10 Hypothesised pro-apoptotic mechanism of MG extract in
leukemic cell lines. Due to its phenolic content and antioxidant
activity, MG ethanolic extract induces a decrease of ROS intracellular
level. In leukemic cell, ROS decrease has been related to FAS
recruitment leading to the activation of the extrinsic apoptotic
pathway. A possible explanation of the observed increase of BAX/
BCL-2 ratio consists in the fact that FAS ligands lead to apoptosis
through caspase-8 activation which on one hand promote the
extrinsic apoptotic pathway, while on the other promote mitochondrial
membrane potential loss through BAX/BCL2 ratio increase
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leukaemic cell lines and also in cells from patients with
different types of leukaemia [59]. Therefore, it is gener-
ally accepted that increased ROS production is import-
ant for the proliferation of hematological malignancies
[60, 61]. Due to ROS importance in sustaining leukemic
cell proliferation and survival, the reduction of their
levels could represent an effective strategy to reduce
leukemic cells proliferation [59]. Moreover, Aronis et al.
[62] demonstrated that a reduced ROS level could in-
duce apoptosis by the involvement of death receptor in
Jurkat cells.
In this context, our data show MG ability to exert
scavenging and antioxidant activity leading to a signifi-
cant reduction of ROS intracellular level which contrib-
utes to explain the pro-apoptotic effect induced by the
activation of the extrinsic apoptotic pathway as indicated
by FAS increased expression level.
The hypothesised pro-apoptotic mechanism of MG ex-
tract is summarized in the scheme shown in Fig. 10.
A fundamental feature of a good chemopreventive
agent is the low toxicity towards healthy cells and the
relative selectivity of action against tumor cells [63].
Therefore, the study was completed by evaluating MG
cytotoxicity on PBL after 24 h of treatment.
MG demonstrated good selectivity as shown by the
IC50, calculated for PBL by interpolation of the dose re-
sponse curve, that resulted 2 and 1.7 times higher than
those obtained on Jurkat and HL-60 cells respectively.
Conclusions
MG demonstrated good pro-apoptotic capacity in both
Jurkat and HL-60 cell lines, with a predominant antipro-
liferative effect in HL-60 and to be partially selective to-
wards leukemic cells. These findings allow to propose
MG extracts as possible candidate as chemopreventive
agents.
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